Praphaphimon Pariwat. Pharmacological characterization of steviol and its derivative for the treatment of secretory diarrhea. Doctoral Degree(Physiology). Mahidol University. Mahidol University Library and Knowledge Center. : Mahidol University, 2009.
Pharmacological characterization of steviol and its derivative for the treatment of secretory diarrhea
Abstract:
Stevioside and its major metabolite, steviol, have been reported to affect ion
transport in many types of tissue, such as the kidney, pancreas and intestine.
However, the effect of stevioside, steviol and its derivatives on intestinal chloride
secretion is still unknown. In the study, the effect of stevioside, steviol and its
derivatives on intestinal Cl- secretion was investigated by using a human T84
epithelial cell line and mouse intestinal closed-loop model. In vitro studies using short
circuit current measurements showed that stevioside had no effect on chloride
secretion whereas its major metabolite, steviol, and other analogs including isosteviol,
dihydroisosteviol and isosteviol 16-oxime, inhibited forskolin-induced Cl- secretion in
a dose-dependent manner with IC50 of 101, 100, 9.6 and 50 μM, respectively. The
apical Cl- current measurement indicated that dihydroisosteviol probably targeted
CFTR. Moreover, the inhibitory action of dihydroisosteviol was reversible and was
not associated with changes in intracellular cAMP level. In addition,
dihydroisosteviol did not affect calcium-activated chloride secretion and T84 cell
viability. In vivo studies using a mouse closed loop model of cholera toxin-induced
intestinal fluid secretion showed that intraluminal injection of 50 μM
dihydroisosteviol reduced intestinal fluid secretion by 89% without altering fluid
absorption whereas intraperitoneal injection of dihydroisosteviol had no effect on
intestinal fluid secretion. In conclusion, among derivatives of steviol,
dihydroisosteviol and similar compounds could be a new class of CFTR inhibitors
useful for further development as antidiarrheal agents.